Filing Details
- Accession Number:
- 0001213900-19-026361
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-17 17:09:10
- Reporting Period:
- 2019-12-13
- Accepted Time:
- 2019-12-17 17:09:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410098 | Cormedix Inc. | CRMD | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1505888 | Mehmood Khan | C/O Cormedix Inc. 400 Connell Drive, Suite 5000 Berkeley Heights NJ 07922 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-13 | 17,000 | $6.58 | 133,017 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy Common Stock) | $8.30 | 2029-01-10 | 15,000 | 15,000 | Direct | |
| Common Stock | Stock Option (Right to Buy Common Stock) | $2.85 | 2028-02-16 | 8,000 | 8,000 | Direct | |
| Common Stock | Stock Option (Right to Buy Common Stock) | $2.25 | 2027-06-25 | 15,000 | 15,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2029-01-10 | 15,000 | 15,000 | Direct |
| 2028-02-16 | 8,000 | 8,000 | Direct |
| 2027-06-25 | 15,000 | 15,000 | Direct |
Footnotes
- Reflects the weighted average price of purchases made on the NYSE American on December 13, 2019. The shares were purchased in multiple transactions at prices ranging from $6.47 to $6.75, inclusive. The reporting person undertakes to provide to CorMedix Inc., any security holder of CorMedix Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
- These options were granted on 01/10/2019. These options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
- These options were granted on 02/16/2018. These options are fully vested.
- These options were granted on 06/25/2017. These options are fully vested.
Billionaire Hedge Funds
